Ibex Medical Analytics

Ibex develops AI-powered diagnostic solutions that help pathologists detect and diagnose cancer with greater accuracy and efficiency. The company's platform analyzes pathology slides using deep learning algorithms trained on millions of tissue samples, providing real-time cancer detection across multiple cancer types including breast, prostate, and gastric cancers.

The company is the worldwide leader in live clinical AI deployments for pathology, with installations across healthcare systems globally. Ibex raised $55 million in Series C funding led by 83North, with participation from Sienna Venture Capital, Octopus Ventures, aMoon Fund, and Dell Technologies Capital.

Dual-use relevance is meaningful: AI-powered pathology diagnostics can serve both civilian healthcare networks and military medical systems, where rapid and accurate cancer screening for military personnel and veterans is a significant need. The technology also has applications in military field hospital pathology and telehealth-enabled remote diagnostics for deployed forces.